Pages that link to "Q33840143"

The following pages link to Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. (Q33840143):

Displaying 31 items.

• Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis (Q26779846) (← links)
• Key Fibrogenic Signaling (Q26995788) (← links)
• Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis. (Q33670231) (← links)
• RhoA GTPase-induced ocular hypertension in a rodent model is associated with increased fibrogenic activity in the trabecular meshwork (Q35008515) (← links)
• Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. (Q35236478) (← links)
• Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat (Q35849718) (← links)
• Low intensity 635 nm diode laser irradiation inhibits fibroblast-myofibroblast transition reducing TRPC1 channel expression/activity: New perspectives for tissue fibrosis treatment (Q35867525) (← links)
• TGF-β signaling in the kidney: profibrotic and protective effects (Q36775661) (← links)
• ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation. (Q37684020) (← links)
• Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma (Q38731620) (← links)
• Molecular mechanisms of atrial fibrosis: implications for the clinic (Q38749008) (← links)
• Myofibroblasts and inflammatory cells as players of cardiac fibrosis (Q38925162) (← links)
• Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research (Q38946178) (← links)
• Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort. (Q40651848) (← links)
• Hierarchy of molecules in TGF-β1 signaling relevant to myofibroblast activation and renal fibrosis (Q42806311) (← links)
• PDGFR Signaling Mediates Hyperproliferation and Fibrotic Responses of Subsynovial Connective Tissue Cells in Idiopathic Carpal Tunnel Syndrome. (Q47102830) (← links)
• Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity (Q47856782) (← links)
• Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma (Q50947105) (← links)
• Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma. (Q51101236) (← links)
• Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells. (Q52574347) (← links)
• In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype. (Q54284559) (← links)
• The role of DOCK10 in the regulation of the transcriptome and aging (Q64058413) (← links)
• Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies (Q89489017) (← links)
• Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds (Q89623894) (← links)
• Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring (Q89658423) (← links)
• Haploinsufficient Rock1+/- and Rock2+/- Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis (Q90363529) (← links)
• Emerging targets of disease-modifying therapy for systemic sclerosis (Q91845024) (← links)
• Moesin, an ERM family member, regulates hepatic fibrosis (Q92150484) (← links)
• RhoGTPase in Vascular Disease (Q92589761) (← links)
• 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma (Q92875864) (← links)
• Cardiac dysfunction is attenuated by ginkgolide B via reducing oxidative stress and fibrosis in diabetic rats (Q99579444) (← links)